i want to learn about glp-1 The Solution | Book by Gianna Beasley | Official Publisher Page How Do You Know When

In January, the first GLP-1 receptor agonist, semaglutide (Ozempic, Novo Nordisk), was approved by the FDA for use by adults with type 2 diabetes and chronic kidney disease to reduce the risk for worsening CKD and kidney failure

Ensure the capsules are tightly sealed in their original packaging to maintain their integrity and prevent contamination

259 A double-blind placebo-controlled trial randomized 56 healthy individuals aged 2565 years with borderline cardiovascular disease (CVD) risk factors to receive placebo or 500 mg aged black garlic (providing 2.5 mg SAC) for 12 weeks

Semaglutide injection for the treatment of adults with type 2 diabetes